Insights into mitofusin-2 and endoplasmic reticulum stress regulation in adipose-derived mesenchymal stem cells senescence.

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

This article comments on the study by Fang, which demonstrates that reduced nuclear factor erythroid-derived 2 (NRF2) activity promotes endoplasmic reticulum stress and senescence in adipose-derived mesenchymal stem cells from hypertrophic obese mice, primarily through downregulation of mitofusin-2 (MFN2). Robust methodologies, including knockdown/rescue experiments, chromatin immunoprecipitation quantitative polymerase chain reaction, co-immunoprecipitation, and transplantation assays, substantiate that NRF2 or MFN2 disruption impairs the therapeutic potential of these cells in insulin resistance. However, the proposed MFN2-binding immunoglobulin protein interaction remains indirectly supported and requires biochemical validation ( e.g. , glutathione S-transferase pull-down/Forster resonance energy transfer/cross-linking mass spectrometry). Moreover, NRF2 may influence endoplasmic reticulum stress and senescence through additional unexplored targets. Future studies should clarify the structural and functional nature of the MFN2-binding immunoglobulin protein relationship and its implications for mitochondrial dynamics, endoplasmic reticulum-mitochondria tethering, and calcium signaling.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.